Preadmission Insulin-Treated Type 2 Diabetes Mellitus Patients Had Increased Mortality in Intensive Care Units.
Rongping FanLei XieXuemin PengBo YuHuajie ZouJiaojiao HuangXuefeng YuDaowen WangYan YangPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2022)
Preadmission insulin treatment was associated with increased mortality rate and longer length of ICU stay among T2DM patients in ICU. Preadmission insulin-treated T2DM patients might have worse clinical outcomes when they are critically ill.
Keyphrases
- end stage renal disease
- newly diagnosed
- intensive care unit
- chronic kidney disease
- type diabetes
- ejection fraction
- glycemic control
- prognostic factors
- peritoneal dialysis
- cardiovascular events
- insulin resistance
- adipose tissue
- coronary artery disease
- mechanical ventilation
- skeletal muscle
- patient reported
- smoking cessation
- acute respiratory distress syndrome